Is the market overlooking the value in small caps?
Why is BESS demand set to surge?
Are the conditions for an EM super‑cycle re‑emerging?
Is tracking error a misunderstood metric?
Which companies may benefit from the country’s policies?
How can investors build resilient portfolios to tap biodiversity’s growth...
When the market undervalues, opportunity knocks.
When markets overreact, disciplined investors stay patient.
Why have some large health care companies underperformed?
Policy changes and economic shifts are creating fresh prospects for investors...
Where can investors find growth in the biodiversity transition?
Investor optimism may exceed stateside stocks’ growth potential.